JG
ARCT icon

Jain Global’s Arcturus Therapeutics ARCT Stock Holding History

Jain Global’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.8K Sell
10,085
-11,103
-52% -$87.5K ﹤0.01% 1654
2026
Q1 		$164K Sell
21,188
-22,897
-52% -$167K ﹤0.01% 1106
2025
Q4 		$270K Buy
+44,085
New +$476K ﹤0.01% 983
2025
Q2 		– Sell
-14,622
Closed -$155K – 1177
2025
Q1 		$155K Buy
+14,622
New +$232K ﹤0.01% 910

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jain Global's ARCT Position: Q2 2026 in Review

Jain Global reduced its Arcturus Therapeutics (ARCT) stake by 52% in Q2 2026, selling an estimated $87.5K and leaving 10,085 shares worth $67.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1654.

Jain Global first reported a position in ARCT in Q1 2025 and has held it in 4 quarters since. The position peaked at $270K in Q4 2025. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Jain Global held 10,085 shares of Arcturus Therapeutics worth $67.8K as of Q2 2026.
  • Jain Global sold 11,103 Arcturus Therapeutics shares in Q2 2026, an estimated $87.5K.
  • Arcturus Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1654 holding.
  • Jain Global first reported a position in Arcturus Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Jain Global's Arcturus Therapeutics position peaked at $270K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.